Showing results (241-250 of 306) with videos related to
Sort By:
Pageof 31
European Journal of Cancer (Oxford, England : 1990)|May 21, 2013
Ovarian cancer: Ion channel and aquaporin expression as novel targets of clinical potentialJulia Frede, Scott P Fraser, Gülten Oskay-Özcelik, et al.Turkish Archives of Pediatrics|June 15, 2023
A Novel Interleukin 17 Receptor A Mutation in a Child with Chronic Mucocutaneous Candidiasis and Staphylococcal Skin InfectionsNalan Yakıcı, Sevil Oskay Halaçlı, Çağman Tan, et al.Journal of Gynecologic Oncology|April 7, 2021
Primary platinum resistance and its prognostic impact in patients with recurrent ovarian cancer: an analysis of three prospective trials from the NOGGO study groupFabian Trillsch, Sven Mahner, Bastian Czogalla, et al.Gynecologic Oncology|December 5, 2009
Sequential chemotherapy with carboplatin followed by weekly paclitaxel in advanced ovarian cancer: results of a multicenter phase II study of the northeastern German society of gynecological oncologyG Oskay-Ozcelik, R Chekerov, H Sommer, et al.Clinical Immunology (Orlando, Fla.)|June 29, 2015
STK4 (MST1) deficiency in two siblings with autoimmune cytopenias: A novel mutationSevil Oskay Halacli, Deniz Cagdas Ayvaz, Cagman Sun-Tan, et al.Cancer Chemotherapy and Pharmacology|January 22, 2009
Pegylated liposomal doxorubicin (CAELYX) in patients with advanced ovarian cancer: results of a German multicenter observational studyJalid Sehouli, O Camara, M Schmidt, et al.Archives of Gynecology and Obstetrics|March 6, 2019
Patients' perspectives towards malignant ascites: results of a prospective observational trial regarding expectations, characteristics and quality of life-a study of the North-Eastern-German Society of Gynecological OncologyRobert Armbrust, C Neeb, P Thuss-Patience, et al.Anticancer Research|September 21, 2012
Health-related quality of life during sequential chemotherapy with carboplatin followed by weekly paclitaxel in advanced ovarian cancer: a multicenter phase ii study of the North Eastern German Society of Gynecological OncologyRolf Richter, Guelten Oskay-Oezcelik, Radoslav Chekerov, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2002
A phase II study of topotecan plus gemcitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapyJ Sehouli, D Stengel, G Oskay, et al.Journal of Clinical Immunology|February 15, 2020
Lymphocyte Subgroups and KREC Numbers in Common Variable Immunodeficiency: A Single Center StudyIsmail Yaz, Begum Ozbek, Yuk Yin Ng, et al.Pageof 31